ghk-cu hair growth human clinical trial Dosage and Protocol: The 30-Day Cycle ghk cu hair growth human

It summarizes published preclinical and laboratory research information related to 5-Amino-1MQ (commonly supplied as 5-amino-1-methylquinolinium iodide) as an NNMT inhibitor research tool

All products listed on this site are for in-vitro and pre-clinical research purposes only

The most-cited study (Pyo et al

Can GHK-Cu be combined with retinoids

Clinical research has demonstrated that GHK-Cu is able to pass through the lipid barrier of the stratum corneum (the uppermost layer of skin) and to reach epidermal cells

10 mg vial + 2 mL BAC water: Concentration = 5,000 mcg/mL (5 mg/mL) 5 mg dose = 100 units (1.0 mL) on a 100-unit insulin syringe 10 mg dose = entire vial (use two 100-unit draws or reconstitute with 1 mL for 10 mg/mL) Doses per vial: 2 doses at 5 mg, or 1 dose at 10 mg Supplies Needed (20-Day Cycle at 5 mg/day) 10 vials Epithalon (10 mg each) provides 20 doses at 5 mg 1 vial bacteriostatic water (30 mL) 20 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique Epithalon is administered via subcutaneous (SubQ) injection